goat polyclonal anti il 33 r d systems cat (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
goat polyclonal anti il 33 r d systems cat
Goat Polyclonal Anti Il 33 R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 290 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+anti+il+33+r+d+systems+cat/Mouse+IL-33+Antibody/pm39079535-257-11-14
Average 94 stars, based on 290 article reviews
Goat Polyclonal Anti Il 33 R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 290 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+anti+il+33+r+d+systems+cat/Mouse+IL-33+Antibody/pm39079535-257-11-14
Average 94 stars, based on 290 article reviews
goat polyclonal anti il 33 r d systems cat - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Recombinant:Article Title: Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Article Snippet: In brief Interleukin (IL)-33 release is associated with cell death in the tumor microenvironment, and it has varied effects on tumor development and progression.. In a model of squamous cell carcinoma, Erickson et al. show that cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype. Synthesized:Article Title: Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Article Snippet: In brief Interleukin (IL)-33 release is associated with cell death in the tumor microenvironment, and it has varied effects on tumor development and progression.. In a model of squamous cell carcinoma, Erickson et al. show that cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype. Imaging:Article Title: Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Article Snippet: In brief Interleukin (IL)-33 release is associated with cell death in the tumor microenvironment, and it has varied effects on tumor development and progression.. In a model of squamous cell carcinoma, Erickson et al. show that cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype. Selection:Article Title: Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Article Snippet: In brief Interleukin (IL)-33 release is associated with cell death in the tumor microenvironment, and it has varied effects on tumor development and progression.. In a model of squamous cell carcinoma, Erickson et al. show that cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype. |